Is Ketorolac Tromethamine Injection in shortage?
Yes. Ketorolac Tromethamine Injection is on FDA’s drug shortage list (unavailable), last updated Oct 6, 2026.
Why it’s in shortage
- Delay in shipping of the drug
- Demand increase for the drug
- Other
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01)
Check wholesalers for inventory
Maker contact: 888-386-1300
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10)
Estimated recovery: TBD
Maker contact: 888-386-1300
- Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20)
Estimated recovery: TBD
Maker contact: 888-386-1300
- Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10)
Estimated recovery: TBD
Maker contact: 888-386-1300
- Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)
Estimated recovery: December 2026
Maker contact: 888-229-0001
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)
Maker contact: 888-229-0001
- Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01)
Next Delivery and Estimated Recovery: December 2027
Maker contact: 844-646-4398
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01)
Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
- Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01)
Next Delivery and Estimated Recovery; December 2027; Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
- Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25)
Estimated recovery: TBD
Maker contact: 800-631-2174
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25)
Estimated recovery: TBD
Maker contact: 800-631-2174
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25)
Estimated recovery: TBD
Maker contact: 800-631-2174
- Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)
Estimated recovery: late September 2026, Product in transit
Maker contact: 866-625-1618
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)
Maker contact: 866-625-1618
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)
Maker contact: 866-625-1618
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01)
Next release October 2026. Check wholesalers for inventory.
Maker contact: 888-386-1300
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02)
Next release October 2026. Check wholesalers for inventory.
Maker contact: 888-386-1300
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25)
Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.
Maker contact: 833-291-9645
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25)
Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.
Maker contact: 833-291-9645
- Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25)
Maker contact: 908-393-9604
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25)
Maker contact: 908-393-9604
- Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)
Maker contact: 908-393-9604
FDA recalls of Ketorolac Tromethamine
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Ketorolac Tromethamine Injection:
- Aspiro Pharma Limited recalls Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx
- Apotex Corp. recalls Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill,
- Apotex Corp. recalls Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontario,
- Nephron Sc Inc recalls Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only, Nephron
- Fresenius Kabi USA, LLC recalls Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL
- Fresenius Kabi USA, LLC recalls Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only,
- Fresenius Kabi USA, LLC recalls Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vials (NDC
- Fresenius Kabi USA, LLC recalls Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL
- Hikma Pharmaceuticals USA Inc. recalls Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL Single Dose Vials (NDC 0641-6042-01), 25
- Hikma Pharmaceuticals USA Inc. recalls Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043-01), 25
- Sagent Pharmaceuticals Inc recalls Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), 2 mL Vials, Rx only, Mfd. for Sagent
- Hospira Inc. recalls KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake
Other forms on FDA’s list
Ketorolac Tromethamine Injection shortage questions
Is Ketorolac Tromethamine Injection in shortage?
Yes. Ketorolac Tromethamine Injection is on FDA’s drug shortage list (unavailable), last updated Oct 6, 2026.
Why is there a Ketorolac Tromethamine Injection shortage?
FDA records the reason as: Delay in shipping of the drug; Demand increase for the drug; Other.
What should I do if I can’t get Ketorolac Tromethamine Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.